MedPath

CENNLACS

CENNLACS

Discontinued
DIN Number

00552682

Drug Class

Human

Market Date

Dec 31, 1983

Company
HC

westward distributors

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00552682
AIG Number0215135001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A06AB56 SENNA GLYCOSIDES, COMBINATIONS
Product Specifications
Dosage FormPowder
Route of AdministrationOral
AHFS Classification56:12.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

GLYCYRRHIZA GLABRAActive
Strength: 182 MG / G
Monograph: GLYCYRRHIZA GLABRA
SENNAActive
Strength: 726 MG / G
Monograph: SENNA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.